Pharmaceutical

Sobi and Enable Injections partner for Aspaveli distribution

Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.

Sep 14, 2024 - 04:00
Sobi and Enable Injections partner for Aspaveli distribution
Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.
Read the original article

Tags:

Previous Article

Cidara axes 30% of staff to focus on flu prevention drug

Next Article

FDA approves Roche’s Tecentriq Hybreza for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bernie Sanders plans more drug price caps as big pharma fights back

Bernie Sanders plans more drug price caps as big pharma...

Jul 29, 2023

Europe recommends the approval of Pfizer’s RSV vaccine for older adults and in pregnancy

Europe recommends the approval of Pfizer’s RSV vaccine ...

Jul 22, 2023

Pancreatic cancer: The clinical trial landscape and progress for 2024 

Pancreatic cancer: The clinical trial landscape and pro...

Sep 24, 2024